Livagen 20 mg

Livagen is a short peptide bioregulator developed within the Khavinson school of peptide research at the Saint Petersburg Institute of Bioregulation and Gerontology. Classified as a tetrapeptide oligopeptide with the sequence Lys-Glu-Asp-Ala (KEDA), Livagen was developed to investigate how minimal peptide sequences interact with hepatic tissue and lymphocyte chromatin research models. Its compact structure positions Livagen as a useful research compound for studying tissue-specific peptide signaling in laboratory contexts.

At the cellular and molecular level, Livagen is studied for its proposed ability to engage with chromatin structure and modulate transcriptional activity within hepatocytes and lymphocyte cell models. Research observations within the Khavinson framework suggest that short bioregulator peptides interact with specific DNA regions to influence the expression of genes associated with hepatic enzyme synthesis, hepatocyte renewal, and lymphocyte chromatin organization. These observations are consistent with the broader proposition that short peptides act as gene-expression regulators within tissues from which their parent peptide complexes were originally extracted.

Research interest in Livagen centers on liver-tissue gene expression studies, hepatocyte renewal research models, and lymphocyte chromatin investigations. Comparative work on tissue-specific bioregulators positions Livagen alongside other liver-targeted oligopeptides used to explore peptidergic regulation of hepatic biology in cell-culture and animal research models (Khavinson V.K., Anisimov V.N., 2009, Advances in Gerontology). Additional reports within the Khavinson tradition describe how the KEDA sequence influences heterochromatin decondensation and gene-expression activation in lymphocyte research models, supporting continued laboratory investigation of Livagen in hepatic and chromatin biology research.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

See also: Pancragen 20 mg, Cartalax 20 mg, and Cortagen 20 mg.

Specifications

• Purity: 99%
• Quantity: 20 mg
• Molecular Formula: N/A
• Molecular Weight: N/A